GPi vs STN deep brain stimulation for Parkinson disease

Neurology

Volumn 86, Issue 8, 2016, Pages 755-761

  Odekerken, Vincent J J ^a   Boel, Judith A ^a,b   Schmand, Ben A ^a,b   De Haan, Rob J ^a   Figee, M ^a   Van Den Munckhof, Pepijn ^a   Schuurman, P Richard ^a   De Bie, Rob M A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; BROMOCRIPTINE; ENTACAPONE; LEVODOPA; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE;

ADULT; AMC LINEAR DISABILITY SCALE SCORE; ARTICLE; BALANCE DISORDER; BILATERAL GLOBUS PALLIDUS PARS INTERNA BRAIN DEPTH STIMULATION; BILATERAL SUBTHALAMIC NUCLEUS BRAIN DEPTH STIMULATION; BRAIN DEPTH STIMULATION; BRAIN HEMORRHAGE; BRAIN INFARCTION; CONTROLLED STUDY; DELIRIUM; DEVICE INFECTION; DYSARTHRIA; DYSKINESIA; DYSPHAGIA; DYSPHASIA; ELECTRODE; EPILEPSY; FACIAL NERVE PARALYSIS; FEMALE; FOLLOW UP; GLOBUS PALLIDUS; HICCUP; HUMAN; HYPERSALIVATION; IATROGENIC DISEASE; INTENTION TO TREAT ANALYSIS; INTERMETHOD COMPARISON; LEAD MIGRATION; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; MENTAL INSTABILITY; MULTICENTER STUDY (TOPIC); NEUROLOGIC DISEASE ASSESSMENT; OCULOMOTOR NERVE DISEASE; OUTCOME ASSESSMENT; PARESIS; PARKINSON DISEASE; PARKINSON'S DISEASE QUALITY OF LIFE QUESTIONNAIRE; PARKINSON'S DISEASE SLEEP SCALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REOPERATION; SENSORY DYSFUNCTION; SUBTHALAMIC NUCLEUS; THERAPEUTIC EQUIVALENCE; TREATMENT FAILURE; UNIFIED PARKINSON DISEASE RATING SCALE; AGED; COMPARATIVE STUDY; MIDDLE AGED; NETHERLANDS; PHYSIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TRENDS;

AGED; DEEP BRAIN STIMULATION; FEMALE; FOLLOW-UP STUDIES; GLOBUS PALLIDUS; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PARKINSON DISEASE; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME;

EID: 84959238046     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000002401     Document Type: Article

References (36)

1. Vidailhet M. Movement disorders in 2010: Parkinson disease: symptoms and treatments. Nat Rev Neurol 2011;7: 70-72.
2. Odekerken VJ, van Laar T, Staal MJ, et al. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial. Lancet Neurol 2013;12:37-44.
3. Anderson VC, Burchiel KJ, Hogarth P, Favre J, Hammerstad JP. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease. Arch Neurol 2005;62:554-560.
4. Follett KA, Weaver FM, Stern M, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med 2010;362:2077-2091.
5. Tagliati M. Turning tables: should GPi become the preferred DBS target for Parkinson disease? Neurology 2012; 79:19-20.
6. Bejjani BP, Damier P, Arnulf I, et al. Transient acute depression induced by high-frequency deep-brain stimulation. N Engl J Med 1999;340:1476-1480.
7. Kulisevsky J, Berthier ML, Gironell A, Pascual-Sedano B, Molet J, Pares P. Mania following deep brain stimulation for Parkinson's disease. Neurology 2002;59:1421-1424.
8. Rodriguez-Oroz MC, Obeso JA, Lang AE, et al. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain 2005;128:2240-2249.
9. Weaver FM, Follett KA, Stern M, et al. Randomized trial of deep brain stimulation for Parkinson disease: thirty-sixmonth outcomes. Neurology 2012;79:55-65.
10. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442.
11. Mattis S. Dementia Rating Scale Professional Manual. Odessa: Psychological Assessment Resources; 1973.
12. de Bie RM, de Haan RJ, Nijssen PC, et al. Unilateral pallidotomy in Parkinson's disease: a randomised, singleblind, multicentre trial. Lancet 1999;354:1665-1669.
13. Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 1975;31:103-115.
14. Esselink RA, de Bie RM, de Haan RJ, et al. Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: a randomized trial. Neurology 2004;62:201-207.
15. Fahn S, Elton R; The Members of the UPDRS Development, Committee. Unified Parkinson's disease rating scale. Fahn S, Marsden CD, Calne DB, editors. Recent Developments in Parkinson's Disease. Florham Park, NJ: Macmillan Healthcare Information; 1987:153-163.
16. Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991;59:12-19.
17. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini- International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(suppl 20):22-33; quiz 34-57.
18. Reitan RM. Trail Making Test Manual for Administration and Scoring. Tucson: Reitan Neuropsychological Laboratory; 1992.
19. Rey A. l'Éxamen Clinique en Psychologie. Paris: Presses Universitaires de France; 1964.
20. Rosen WG. Verbal fluency in aging and dementia. J Clin Neuropsychol 1980;2:135-146.
21. Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol 1935;1935:643-662.
22. Wechsler D. WAIS-III Administration and Scoring Manual. San Antonio, TX: The Psychological Corporation; 1997.
23. Hagell P, Widner H. Clinical rating of dyskinesias in Parkinson's disease: use and reliability of a new rating scale. Mov Disord 1999;14:448-455.
24. Gillingham FJ, Donaldson MC, editors. Schwab and England activities of daily living. Presented at the third symposium of Parkinson's disease; Edinburgh; E&S Livingstone; 1969:152-157.
25. Chaudhuri KR, Pal S, DiMarco A, et al. The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psychiatry 2002;73:629-635.
26. de Boer AG, Wijker W, Speelman JD, de Haes JC. Quality of life in patients with Parkinson's disease: development of a questionnaire. J Neurol Neurosurg Psychiatry 1996; 61:70-74.
27. Williams NR, Foote KD, Okun MS. STN vs GPi deep brain stimulation: translating the rematch into clinical practice. Mov Disord Clin Pract 2014;1:24-35.
28. Carod-Artal FJ, Ziomkowski S, Mourao Mesquita H, Martinez-Martin P. Anxiety and depression: main determinants of health-related quality of life in Brazilian patients with Parkinson's disease. Parkinsonism Relat Disord 2008;14:102-108.
29. Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatry 2000;69:308-312.
30. Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006;355:896-908.
31. Fenoy AJ, Simpson RK Jr. Risks of common complications in deep brain stimulation surgery: management and avoidance. J Neurosurg 2014;120:132-139.
32. Deep-Brain Stimulation for Parkinson's Disease Study Group. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 2001;345:956-963.
33. Burchiel KJ, Anderson VC, Favre J, Hammerstad JP. Comparison of pallidal and subthalamic nucleus deep brain stimulation for advanced Parkinson's disease: results of a randomized, blinded pilot study. Neurosurgery 1999; 45:1375-1382; discussion 1382-1374.
34. Weaver FM, Follett K, Stern M, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 2009;301:63-73.
35. Houeto JL, Bejjani PB, Damier P, et al. Failure of longterm pallidal stimulation corrected by subthalamic stimulation in PD. Neurology 2000;55:728-730.
36. Volkmann J, Allert N, Voges J, Sturm V, Schnitzler A, Freund HJ. Long-term results of bilateral pallidal stimulation in Parkinson's disease. Ann Neurol 2004;55: 871-875.